Inflammation in Neuropsychiatric Disorders

Erscheinungsjahr 2012
ISBN: 978-0-12-398314-5
Verlag: William Andrew Publishing

Buch, Englisch, 200 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 480 g

Published continuously since 1944, the Advances in Protein Chemistry and Structural Biology serial has been a continuous, essential resource for protein chemists. Covering reviews of methodology and research in all aspects of protein chemistry, including purification/expression, proteomics, modeling and structural determination and design, each volume brings forth new information about protocols and analysis of proteins while presenting the most recent findings from leading experts in a broad range of protein-related topics.

Zielgruppe

Biochemists, biophysicists, cell biologists, protein chemists, structural geneticists, and structural biologists

Autoren/Hrsg.

Weitere Mitwirkende

Donev, Rossen

Fachgebiete

• Naturwissenschaften Biowissenschaften Biochemie (nichtmedizinisch)
• Naturwissenschaften Chemie Organische Chemie Biochemie
• Naturwissenschaften Biowissenschaften Proteinforschung
• Naturwissenschaften Biowissenschaften Molekularbiologie

Inhaltsverzeichnis

- Inflammation in Anxiety

Samina Salim, Gaurav Chugh and Mohammad Asghar

- Inflammation-Related Disorders in the Tryptophan Catabolite (TRYCAT) Pathway in Depression and Somatization

George Anderson, Michael Maes and Michael Berk

- Inflammation in Schizophrenia

Norbert Müller, Aye-Mu Myint and Markus J. Schwarz

- Inflammation in Parkinson's Disease

Kemal Ugur Tufekci, Ralph Meuwissen, Sermin Genc and Kursad Genc

- Treatment with Aß42 Binding D-Amino Acid Peptides Reduce Amyloid Deposition and Inflammation in APP/ PS1 Double Transgenic Mice Thomas van Groen, Inga Kadish, Aileen Funke, Dirk Bartnik and Dieter Willbold

Über Autor(innen)

Donev, Rossen
Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on development of immunotherapeutics for non-systemic applications.